课题基金 / 基金详情

STUDIES OF IL-18 IN CHILDREN WITH REFRACTORY ATOPIC DERMATITIS

STUDIES OF IL-18 IN CHILDREN WITH REFRACTORY ATOPIC DERMATITIS
IL-18 在难治性特应性皮炎儿童中的研究
批准号:
13670818
负责人:
MATSUMOTO Tomoaki
金额:
$1.73万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2004

项目摘要

项目成果

MATSUMOTO Tomoaki的其他基金

相似基金

相关文献

中文摘要
翻译
白细胞介素(IL)-18是一种促炎细胞因子,现在被认为是辅助性T细胞(Th)1和2细胞因子产生的重要调节因子。本研究旨在确定IL-18是否参与儿童难治性特应性皮炎(AD)的发病机制。取难治性AD患儿和无变态反应性疾病的对照组儿童外周血单个核细胞(PBMC),分别用脂多糖(LPS)和植物血凝素(PHA)培养。AD患儿IL-18分泌量(几何平均值(gm)=172 pg/ml)显著高于非过敏儿童(118 pg/ml)。AD患儿IFN-γ分泌量(gm=6.8 IU/ml)明显低于正常对照组(gm=20.7 IU/ml),IL-18与IL-12、IL-2协同诱导IFN-γ合成,本研究探讨IL-18与IL-12或IL-2联合对PBMC产生IFN-γ的体外诱导作用。20名非过敏对照者经IL-18+IL-12刺激后,所有PBMC均检测到IFN-γ产生,但21名AD儿童中有5名的结果低于IFN-γ产生的检测限。与IL-2协同作用,IL-18能够诱导所有非过敏儿童和21名AD儿童中的20名儿童的PBMC产生IFN-γ,这表明大约四分之一的AD儿童参与了IL-12信号级联的损伤。为此,用流式细胞术分析CD 4 + T细胞的IL-12受体表达。AD患儿T4+细胞IL-12 β-1受体表达(6.5±1.9%)与非过敏儿童(6.1±1.1%)比较差异无统计学意义。遗憾的是,对CD 4 + T细胞上IL-12 β-2受体表达的测量尚未成功。
英文摘要
Interleukin(IL)-18 is a proinflammatory cytokine and is now recognized an important regulator of both helper T cells(Th) 1 and 2 cytokine production. This study was performed to determine whether or not IL-18 is involved in the pathogeneses of refractory atopic dermatitis(AD) in childhood. Peripheral blood mononudear cells(PBMC) were obtained from children with refractory AD and control children who did not have any allergic disease, and then cultured with lipopolysaccharide(LPS) or phytohaemagglutinin(PHA). IL-18 secretion in the AD children(geometric mean (gm)=172 pg/ml) was significantly higher than that in non-allergic children(118 pg/ml). In contrast, interferon-gamma(IFN-γ) secretion in the AD children(gm=6.8 IU/ml) was significantly lower than that in non-allergic controls(gm=20.7 IU/ml).Since IL-18 has been known to synergize with IL-12 and IL-2 to induce IFN-γ synthesis, the inducing effect in vitro of combining IL-18 and IL-12 or IL-2 on IFN-γ production by PBMC was investigated. IFN-γ production was detected in all PBMCs from 20 non-allergic controls stimulated with IL-18+IL-12, however, the results for five of 21 AD children were under the detection limit for IFN-γ production. In collaboration with IL-2, IL-18 was able to induce IFN-γ production by PBMCs from all non-allergic children and 20 of 21 AD children, suggesting that impairment of the IL-12 signal cascade was involved in around a quarter of the AD children. For this reason, the CD4+ T cells were analyzed for IL-12 receptor expression with flow cytometry. The results were not statistically different between the AD children(6.5±1.9%) and the non-allergic children (6.1±1.1%) in IL-12 β-1 receptor expression on the T4+ cells. Unfortunately, the measurement for IL-12 β-2 receptor expression on CD4+ T cells has not been succeeded.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1046/j.1365-2249.2001.01664.x
发表时间: 2001-11-01
期刊: CLINICAL AND EXPERIMENTAL IMMUNOLOGY
影响因子: 4.6
作者: [El-Mezzein, REH, Matsumoto, T, Miike, T]
通讯作者: Miike, T
R.E, H.EL-Mezzein: "Increased secretion of IL-18 in vitro by peripheral blood mononuclear cells of patients with bronchial asthma and atopic dermatitis"Clinical and Experimental Immunology. 126巻2号. 193-198 (2001)
R.E, H.EL-Mezzein:“支气管哮喘和特应性皮炎患者的外周血单核细胞体外分泌 IL-18”《临床和实验免疫学》第 126 卷,第 2. 193-198 期(2001 年)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
K.E.EL-Mezzaien: "In vitro responsiveness to IL-18 in combination with IL-12 or IL-2 by PBMC form patients with byonchial asthma and atopic dermatitis"Clinical Immunology. 110巻(in press). (2004)
K.E.EL-Mezzaien:“患有支气管性哮喘和特应性皮炎的患者对 IL-18 与 IL-12 或 IL-2 的体外反应”,《临床免疫学》第 110 卷(出版中)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: 10.1016/j.clim.2003.12.006
发表时间: 2004-04-01
期刊: CLINICAL IMMUNOLOGY
影响因子: 8.6
作者: [El-Mezayen, REH, Matsumoto, T]
通讯作者: Matsumoto, T
Effect of environment in star formation investigated with adaptive mesh refinement
  • 批准号:
    26400233
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.83万
  • 财政年份:
    2014
  • 负责人:
    MATSUMOTO Tomoaki
  • 依托单位:
Star formation in turbulent cloud cores with magnetic diffusion
  • 批准号:
    23540270
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.58万
  • 财政年份:
    2011
  • 负责人:
    MATSUMOTO Tomoaki
  • 依托单位:
Structural changes accompanying mitigation of the allergic action ofovomucoid after passing an electric current
  • 批准号:
    22580138
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.58万
  • 财政年份:
    2010
  • 负责人:
    MATSUMOTO Tomoaki
  • 依托单位:
Magneto-turbulent star formation with adaptive mesh refinement
  • 批准号:
    20540238
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.33万
  • 财政年份:
    2008
  • 负责人:
    MATSUMOTO Tomoaki
  • 依托单位:
国内基金
海外基金
S1P诱导LSEC分泌IL-12调控HBV特异性CTL应答的机制及作为HBeAg阴性慢性乙型肝炎急性发作分型标志物的研究
  • 批准号:
    2025JJ50652
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    吴伟民
  • 依托单位:
Acod 1来源的衣康酸通过表观遗传调控IL-12导致CD8+T细胞功能障碍的
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    刘家洲
  • 依托单位:
IL-12促进γδTreg细胞分化调控高血压的机制研究
  • 批准号:
    82370431
  • 项目类别:
    面上项目
  • 资助金额:
    49万元
  • 批准年份:
    2023
  • 负责人:
    叶晶
  • 依托单位:
一种简单的可用于治疗ARS的IL-12递送可注射纳米复合水凝胶系统